Home › Markets › Health Care › TLRY

Tilray Brands Inc. Common Stock (TLRY)

TLRY trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$3.27
-2.68% on the day
Market cap
$483.3M
Small cap
Revenue · 2025
$915.5M
+11.5% on 2024
Net income · 2025
-$121.4M
-13.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerTLRY on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryUnited States
IPO year2018
SEC CIK0001731348
SEC industry codeMedicinal Chemicals & Botanical Products
Incorporated inDELAWARE

Financials · 2025

LineValue
Revenue$915.5M
Net income-$121.4M
Operating income-$63.0M
Net margin-13.3%
Operating margin-6.9%
Revenue growth+11.5%
Cash$221.7M
Total assets$2.1B
P/E (computed)Net income was not positive
P/S (computed)0.5×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B72026-04-21
Latest annual report
FORM 10-K
10-K2026-07-28
Latest quarterly / interim
FORM 10-Q
10-Q2026-10-08
Latest current report
FORM 8-K
8-K2026-10-08
Latest proxyDEFA14A2026-09-28

Source: SEC EDGAR submissions feed, 770 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-15.8%
1 month-21.5%
3 months-28.0%
Year to date-65.3%
1 year-81.5%
From 52-week high-81.4%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
OBIOOrchestra BioMed Holdings Inc.$5.72-3.21%$343.8M
GLASGlass House Brands Inc. Subordinate Voting Shares$3.85-5.64%$338.8M
CGCCanopy Growth Corporation Common Shares$0.7625+0.66%$322.6M
USNAUSANA Health Sciences Inc.$15.46+3.41%$285.6M
SNDLSNDL Inc. Common Shares$1.16-0.85%$285.5M
ACBAurora Cannabis Inc. Common Shares$4.29-1.38%$265.8M
NAGENiagen Bioscience Inc.$2.58-1.90%$204.1M
CRONCronos Group Inc. Common Share$3.20-0.31%$1.2B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier